This study aims to evaluate in detail the biological osteoconductive properties of the low-temperature synthetic porous calcium-deficient hydroxyapatite and to compare it with the biological apatite. Bone reactions to granules of similar sizes of the low-temperature hydroxyapatite and commercially available non-sintered deproteinized bovine bone were compared. Two different temperatures were used to fabricate two batches of newly developed porous hydroxyapatite with different carbonate groups content and specific surface area. The histological analysis of specimens with histomorphometry was performed at different time after in vivo implantation. Based on histological analysis, the level of bone formation in the spaces between the implanted granules and through the interconnected pores of all implanted materials within a cortical region (bone area ingrowth 72-85 %) was several-fold higher than within a cancellous bone site (bone area ingrowth 16-28 %) at three and six months after implantation. Within the cancellous bone site, bone coverage of the implanted material at six months was significantly higher in hydroxyapatite material fabricated using low-temperature synthesis and subsequent processing at 150°C than in hydroxyapatite scaffold developed using low-temperature synthesis with subsequent processing at 700°C or deproteinized bovine bone. According to our study, the bioactive properties of the low-temperature calcium-deficient hydroxyapatite are comparable with the biological apatite. The favourable influence of a high specific surface area of a low-temperature calcium-deficient hydroxyapatite on in vivo bone formation was emphasized.

Department of Orthopaedic Surgery Faculty of Medicine and University Hospital in Hradec Králové Charles University Prague Sokolská 581 500 05 Hradec Králové Czech Republic

Zobrazit více v PubMed

Hirn M, Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR. Bone defects following curettage do not necessarily need augmentation. A retrospective study of 146 patients. Acta Orthop. 2009;80:4–8. doi: 10.1080/17453670902804505. PubMed DOI PMC

Sponer P, Urban K, Urbanova E, Karpas K, Mathew PG. Behavior of nonresorbable bioactive glass-ceramic implanted into long bone defects: comparison with cancellous allografts. Arch Orthop Trauma Surg. 2009;129:1353–1360. doi: 10.1007/s00402-009-0839-3. PubMed DOI

Pecina M, Vukicevic S. Biological aspects of bone, cartilage and tendon regeneration. Int Orthop. 2007;31:719–720. doi: 10.1007/s00264-007-0425-7. PubMed DOI PMC

McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft) Int Orthop. 2007;31:729–734. doi: 10.1007/s00264-007-0418-6. PubMed DOI PMC

White AP, Vaccaro AR, Hall JA, Whang PG, Friel BC, McKee MD. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal vision. Int Orthop. 2007;31:735–741. doi: 10.1007/s00264-007-0422-x. PubMed DOI PMC

Bishop GB, Einhorn TA. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop. 2007;31:721–727. doi: 10.1007/s00264-007-0424-8. PubMed DOI PMC

Wopenka B, Pasteris JD. A mineralogical perspective on the apatite in bone. Mater Sci Eng C Biomim Mater Sens Syst. 2005;25:131–143. doi: 10.1016/j.msec.2005.01.008. DOI

Honig JF, Merten HA, Heinemann DE. Risk of transmission of agents associated with Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Plast Reconstr Surg. 1999;103:1324–1325. doi: 10.1097/00006534-199904040-00041. PubMed DOI

Donath K, Breuner GA. A method for the study of undecalcified bones and teeth with attached soft tissues—the sage-schliff (sawing and grinding) technique. J Oral Pathol. 1982;11:318–326. doi: 10.1111/j.1600-0714.1982.tb00172.x. PubMed DOI

Hench LL, Polak JM. Third-generation biomedical materials. Science. 2002;295:1014–1017. doi: 10.1126/science.1067404. PubMed DOI

Wetzel AC, Stich H, Caffesse RG. Bone apposition onto oral implants in the sinus area filled with different grafting materials. A histological study in beagle dogs. Clin Oral Implants Res. 1995;6:155–163. doi: 10.1034/j.1600-0501.1995.060304.x. PubMed DOI

Hartl A, Bitzan P, Wanivenhaus A, Kotz R. Faster integration of human allograft bone than of the bovine substitute Lubboc. Non-randomized evaluation of 20 cases with benign tumors or tumor-like conditions. Acta Orthop Scand. 2004;75:217–220. doi: 10.1080/00016470412331294485. PubMed DOI

Briem D, Linhart W, Lehmann W, Meenen NM, Rueger JM. Long-term results after application of a porous hydroxyapatite ceramic (Endobon) in proximal tibia fractures. Unfallchirurg. 2002;105:128–133. doi: 10.1007/s001130100303. PubMed DOI

Meyer S, Floerkemeier T, Windhagen H. Histological osseointegration of Tutobone®: First results in human. Arch Orthop Trauma Surg. 2008;128:539–544. doi: 10.1007/s00402-007-0402-z. PubMed DOI

Traini T, Valentini P, Iezzi G, Piattelli A. A histologic and histomorphometric evaluation of anorganic bovine bone retrieved 9 years after a sinus augmentation procedure. J Periodontol. 2007;78:955–961. doi: 10.1902/jop.2007.060308. PubMed DOI

Ramaswamy Y, Haynes DR, Berger G, et al. Bioceramics composition modulate resorption of human osteoclasts. J Mater Sci Mater Med. 2005;16:1199–1205. doi: 10.1007/s10856-005-4729-0. PubMed DOI

Flautre B, Descamps M, Delecourt C, Blary MC, Hardouin P. Porous HA ceramic for bone replacement: role of the pores and interconnections—experimental study in the rabbit. J Mater Sci Mater Med. 2001;12:679–682. doi: 10.1023/A:1011256107282. PubMed DOI

Itala AI, Ylanen HO, Ekholm C, Karlsson KH, Aro HT. Pore diameter of more than 100 mm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res. 2001;58:679–683. doi: 10.1002/jbm.1069. PubMed DOI

Pilliar RM, Filiaggi MJ, Wells JD, Grynpas MD, Kandel RA. Porous calcium polyphosphate scaffolds for bone substitute applications—in vitro characterization. Biomaterials. 2001;22:963–972. doi: 10.1016/S0142-9612(00)00261-1. PubMed DOI

Tamai N, Myoui A, Tomita T, Nakase T, Tanaka J, Ochi T, et al. Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res. 2002;59:110–117. doi: 10.1002/jbm.1222. PubMed DOI

Kuroda T. Bone formation and mechanical properties of the cancellous bone defect site filled with hydroxyapatite granules. Nippon Seikeigeka Gakkai Zasshi. 1995;69:1037–1049. PubMed

Lu JX, Gallur A, Flautre B, Anselme K, Deschamps M, Thierry B, Hardouin P. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. J Biomed Mater Res. 1998;42:357–367. doi: 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I. PubMed DOI

Hench LL. Bioactive glasses and ceramics. In: Yamamuro T, Hench LL, Wilson J, editors. Handbook of bioactive ceramics. CRC Press: Boca Raton; 2000.

Afonso A, Santos JD, Vasconcelos M, Branco R, Cavalheiro J. Granules of osteopatite and glass-reinforced hydroxyapatite implanted in rabbit tibiae. J Mater Sci Mater Med. 1996;7:507–510. doi: 10.1007/BF00705433. DOI

Bostrom MPG, Seigerman DA. The clinical use of allografts, demineralized bone matrice, synthetic bone graft substitutes and osteoinductive growth factors: A survey study. HSS J. 2005;1:9–18. doi: 10.1007/s11420-005-0111-5. PubMed DOI PMC

Ogose A, Hotta T, Kawashima H, Kondo N, Gu W, Kamura T, Endo N. Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors. J Biomed Mater Res B Appl Biomater. 2005;72B:94–101. doi: 10.1002/jbm.b.30136. PubMed DOI

Schwarz C, Bornei CR. Biphasic phospho-calcium ceramics used as bone substitutes are efficient in the management of severe acetabular bone loss in revision total hip arthroplasties. Eur J Orthop Surg Traumatol. 2005;15:191–196. doi: 10.1007/s00590-005-0244-8. DOI

Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Gehron Robey P. In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng. 2001;72:96–107. doi: 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A. PubMed DOI

Cordonnier T, Layrolle P, Gaillard J, Langonne A, Sensebe L, Rosset P, Sohier J. 3D environment on human mesenchymal stem cells differentiation for bone tissue engineering. J Mater Sci Mater Med. 2010;21:981–987. doi: 10.1007/s10856-009-3916-9. PubMed DOI

Kasten P, Beyen I, Niemeyer P, Luginbühl R, Bohner M, Richter W. Porosity and pore size of β-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: An in vitro and in vivo study. Acta Biomater. 2008;4:1904–1915. doi: 10.1016/j.actbio.2008.05.017. PubMed DOI

Kasten P, Vogel J, Luginbühl R, Niemeyer P, Tonak M, Lorenz H, Helbig L, Weiss S, Fellenberg J, Leo A, Simank HG, Richter W. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials. 2005;26:5879–5889. doi: 10.1016/j.biomaterials.2005.03.001. PubMed DOI

Utilizing Autologous Multipotent Mesenchymal Stromal Cells and β-Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial